Dec 16, 2024 09:00AM
Nov 7, 2024 09:00AM
Aug 20, 2024 06:41AM
Jan 17, 2024 09:04AM
Jan 17, 2024 09:00AM
May 3, 2023 08:35AM
Apr 11, 2023 08:31AM Xenetic Biosciences (XBIO) Enters Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform
Apr 11, 2023 08:30AM
Jan 11, 2023 01:00PM
Apr 27, 2022 06:33AM
Apr 27, 2022 06:30AM
Jul 26, 2021 07:02AM
Jul 26, 2021 07:00AM
May 12, 2021 07:00AM Xenetic Biosciences, Inc. Reports First Quarter 2021 Financial Results
Mar 29, 2021 08:05AM
Mar 17, 2021 08:00AM
Feb 16, 2021 07:30AM
Dec 14, 2020 11:15AM
Dec 10, 2020 06:26AM
Dec 10, 2020 12:50AM
Dec 9, 2020 08:38AM Xenetic Biosciences (XBIO) Reports Positive Data from PJSC Pharmsynthez's Pivotal Phase 3 Clinical Trial Utilizing PolyXen
Dec 9, 2020 08:35AM
Nov 13, 2020 08:00AM
Aug 13, 2020 07:05AM
Jul 30, 2020 08:05AM
Jul 1, 2020 08:09AM
Jul 1, 2020 08:05AM
Jun 16, 2020 08:05AM Xenetic Biosciences, Inc. Announces Collaboration with Pharmsynthez and Multiple Academic Institutions in Russia and Belarus to Advance Development of XCART(TM) Platform
May 19, 2020 07:36AM
May 19, 2020 07:35AM
May 14, 2020 04:05PM
Apr 15, 2020 08:35AM
Mar 27, 2020 09:00AM
Feb 27, 2020 08:00AM
Feb 26, 2020 08:00AM Xenetic Biosciences, Inc. Appoints Accomplished Biopharmaceutical Executive, Greg MacMichael, Ph.D. to Scientific Advisory Board
Feb 13, 2020 08:00AM
Feb 11, 2020 08:05AM
Jan 14, 2020 08:42AM
Jan 14, 2020 08:35AM
Nov 15, 2019 08:30AM
Oct 29, 2019 07:05AM
Oct 16, 2019 08:05AM Xenetic Biosciences, Inc. to Present at BIO Investor Forum
Oct 8, 2019 08:34AM
Oct 8, 2019 08:30AM
Aug 15, 2019 07:35AM
Jul 22, 2019 08:00AM
Jun 24, 2019 09:13AM
Jun 24, 2019 09:08AM
May 13, 2019 08:05AM Xenetic Biosciences, Inc. Reports First Quarter 2019 Financial Results and Provides Corporate Update
May 13, 2019 08:05AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All